Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Harvard University
- Zintellect
- University of British Columbia
- Northeastern University
- University of Texas at Austin
- City of Hope
- Hong Kong Polytechnic University
- Indiana University
- Nanyang Technological University
- University of Maryland, Baltimore
- University of Oslo
- Carnegie Mellon University
- Center for Drug Evaluation and Research (CDER)
- Dana-Farber Cancer Institute (DFCI)
- Marquette University
- National Center for Toxicological Research (NCTR)
- TAIPEI MEDICAL UNIVERSITY (TMU)
- THE UNIVERSITY OF HONG KONG
- University of California
- Yale University
- AUSTRALIAN NATIONAL UNIVERSITY (ANU)
- Cellular and Molecular Therapeutics Branch, NHLBI, NIH
- Cornell University
- Dana-Farber Cancer Institute
- Ellison Institute of Technology
- Florida Atlantic University
- Georgia Southern University
- LINGNAN UNIVERSITY
- Lingnan University, Hong Kong;
- Max-Planck-Institut für Bildungsforschung
- Mayo Clinic
- National University of Singapore
- Oden Institute for Computational Engineering and Sciences
- Paul Scherrer Institut Villigen
- Ryerson University
- SUNY University at Buffalo
- SciLifeLab
- Tampere University
- The Francis Crick Institute;
- UiT The Arctic University of Norway
- University of Aveiro
- University of Basel
- University of Bergen
- University of Florida
- University of Idaho
- University of New South Wales
- University of North Carolina at Chapel Hill
- University of North Carolina at Charlotte
- University of Notre Dame
- University of Otago
- University of Waterloo
- Vanderbilt University
- Wayne State University
- 43 more »
- « less
-
Field
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 10 hours ago
of biological products to optimize the dose in patients with proteinuria in clinical studies and labeling recommendations. It will help provide guideline on further clinical pharmacology considerations in
-
accelerators for problems that are not efficiently handled by digital systems, such as AI training, real-time optimization, etc. Key Responsibilities: Defining detailed experimental steps. Conducting experiments
-
for 3 years. Responsibilities The successful candidate will: Develop, optimize and validate advanced 3D cell culture models, including spheroids, organoids and tissue-engineered constructs. Establish
-
with demonstrated ability to implement and optimize AI/ML models for biomedical datasets. Preferred Knowledge, Skills and Abilities Mathematical Modeling: Strong foundation in numerical modeling, graph
-
to characterize and manage fracture connectivity and optimize fluid distribution within granites and sedimentary rocks, maximize heat sweep efficiency, reduce preferential flow through highly conductive fractures
-
inference) Algorithmic development for bilevel (or multilevel) optimization Methodological developments in Bayesian statistics and/or decision analysis Application of adversarial risk analysis within security
-
, collaborative study. The fellow will have opportunities to lead studies and peer-reviewed publications, develop and optimize laboratory methods, analyze complex environmental and epidemiologic data, mentor
-
) maximally reduced COVID-19 transmissions while causing fewer disruptions to the community and evaluating the optimal social policy designs in minimising the economic harms of the COVID-19 pandemic through
-
to provide an optimal context for pursuing research toward publications. Consequently, while Fellows have the option of teaching a course in their areas of expertise, teaching does not constitute a requirement
-
to the development of payer value propositions, access narratives, and strategic recommendations that support reimbursement, coverage optimization, and differentiated product positioning Create educational materials